Key Insights
The global veterinary vaccines market, projected for substantial growth, is expected to reach $12.19 billion by 2025, with a compound annual growth rate (CAGR) of 7.2% from 2025 to 2033. Key growth drivers include escalating pet ownership, heightened awareness of animal health and preventive care, and increased governmental investment in animal health due to the prevalence of zoonotic diseases. Technological advancements in vaccine formulation and development, such as improved adjuvants and personalized vaccines, further stimulate market expansion. The market is segmented by vaccine type, administration route, and animal classification (livestock and companion animals), presenting opportunities for specialized product development and targeted marketing.
Veterinary Vaccines Industry Market Size (In Billion)
Despite growth prospects, market expansion faces challenges including high R&D expenditures, stringent regulatory approvals, inconsistent vaccination practices in certain regions, and the presence of counterfeit products. Geographically, North America and Europe currently dominate, but the Asia-Pacific region is poised for significant growth, driven by rising animal populations and increased disposable incomes. Leading market players are actively innovating and expanding their presence.
Veterinary Vaccines Industry Company Market Share
Veterinary Vaccines Market: Size, Share, and Forecast (2025-2033)
This report delivers a comprehensive analysis of the veterinary vaccines industry, forecasting significant market growth. It examines market structure, dynamics, key stakeholders, and emerging trends, providing critical insights for industry professionals, investors, and researchers. The analysis includes detailed market segmentation and growth projections. The forecast period spans from 2025 to 2033, with 2025 serving as the base and estimated year.
Veterinary Vaccines Industry Market Structure & Innovation Trends
This section analyzes the competitive landscape, including market concentration, innovation drivers, and regulatory frameworks impacting the $XX Billion veterinary vaccines market. We examine the role of mergers and acquisitions (M&A) activity, detailing deal values where available. Key aspects covered include:
- Market Concentration: The market exhibits a moderately concentrated structure, with key players like Zoetis and Merck & Co Inc holding significant market share. Smaller companies like SPI Pharma and Bioveta AS contribute to the competitive dynamics. Precise market share data is proprietary to this report.
- Innovation Drivers: The drive towards advanced vaccine technologies, including those using novel adjuvants like liposomes and nanoparticles, is a significant innovation driver. Regulatory approvals and increased demand for disease prevention fuel further innovation.
- Regulatory Frameworks: Stringent regulatory requirements for vaccine efficacy and safety influence the industry landscape. Variations in regulatory approval processes across different regions impact market entry and expansion strategies.
- Product Substitutes: While limited direct substitutes exist, alternative disease prevention methods (e.g., improved hygiene practices) compete with vaccines. The report will explore the impact of these alternatives on market growth.
- M&A Activities: The veterinary vaccines sector has witnessed notable M&A activity, with deal values exceeding $XX Billion in the historical period. This analysis includes a detailed review of past transactions, highlighting the impact on market consolidation and future growth.
- End-User Demographics: The expanding livestock and companion animal populations globally, coupled with rising pet ownership, are major contributors to market growth. This section will analyze these demographic trends.
Veterinary Vaccines Industry Market Dynamics & Trends
This section explores the market's growth trajectory, focusing on key drivers and disruptive forces. We analyze the compound annual growth rate (CAGR) and market penetration rates across different segments and regions.
The veterinary vaccines market exhibits a robust growth trajectory driven by factors including:
- Rising prevalence of animal diseases: Increased awareness about animal health and the incidence of zoonotic diseases drives demand for effective vaccines.
- Government initiatives and regulations: Government support for disease control and vaccination programs globally significantly contributes to market growth.
- Technological advancements: Innovation in vaccine technology, particularly in the development of new adjuvants and delivery systems, enhances vaccine efficacy and safety, fueling market expansion.
- Growing pet ownership: The increasing humanization of pets and rising pet ownership lead to higher demand for companion animal vaccines.
- Emerging markets: Developing economies with expanding livestock sectors present lucrative opportunities for vaccine manufacturers.
Dominant Regions & Segments in Veterinary Vaccines Industry
This section identifies the leading regions, countries, and segments within the veterinary vaccines market. Analysis considers market size, growth rates, and key driving factors.
Leading Regions: The North American and European markets currently dominate, but significant growth is projected in the Asia-Pacific region driven by increasing livestock production and rising disposable incomes.
Dominant Segments:
- By Type: Alum and Calcium Salts currently hold the largest market share due to their established use and cost-effectiveness. However, segments such as Liposomes and Archaeosomes and Nanoparticles and Microparticles are experiencing faster growth due to technological advancements.
- By Route of Administration: Intramuscular administration dominates, but oral vaccines are gaining traction due to ease of administration and reduced stress for animals.
- By Animal Type: Livestock vaccines currently represent a larger market share compared to companion animal vaccines, although companion animal vaccines are experiencing a faster growth rate.
Key Drivers:
- Economic factors: Rising disposable incomes in developing countries are driving demand for animal healthcare, including vaccines.
- Government policies: Government regulations and support for disease control and prevention influence market growth.
- Infrastructure development: Improvements in veterinary infrastructure and access to healthcare contribute to vaccine uptake.
Veterinary Vaccines Industry Product Innovations
Recent product innovations reflect trends towards improved efficacy, safety, and ease of administration. The development of novel adjuvants, such as Evonik's PhytoSquene (launched December 2022), exemplifies this trend, offering a non-animal-derived alternative for parenteral dosage forms. The ICAR-NRC's launch of an inactivated SARS-CoV-2 (Delta) antigen vaccine in June 2022, also highlights advancements in addressing emerging zoonotic disease threats. These innovations enhance market competitiveness by providing advanced solutions for animal health needs.
Report Scope & Segmentation Analysis
This report provides a detailed analysis of the veterinary vaccines market, segmented by:
- By Type: Alum and Calcium Salts, Oil Emulsion Adjuvants, Liposomes and Archaeosomes, Nanoparticles and Microparticles, Other Types. Growth projections vary across these segments, with newer technologies showing higher growth potential.
- By Route of Administration: Oral, Intramuscular, Other Routes of Administration. Intramuscular remains the dominant route, but oral administration is expanding.
- By Animal Type: Livestock, Companion Animal. Both segments are experiencing growth, but the livestock sector currently holds a larger market share.
Key Drivers of Veterinary Vaccines Industry Growth
The veterinary vaccines market is driven by several factors: the increasing prevalence of animal diseases, stringent government regulations promoting vaccination, technological advancements leading to more effective and safer vaccines, rising pet ownership, and expansion into emerging markets. These factors collectively contribute to a positive growth outlook for the industry.
Challenges in the Veterinary Vaccines Industry Sector
The industry faces challenges including stringent regulatory approvals, potential supply chain disruptions impacting vaccine production and distribution, and intense competition among established and emerging players. These factors can impact market profitability and growth rates. Precise quantification of these impacts is available in the full report.
Emerging Opportunities in Veterinary Vaccines Industry
The industry presents significant opportunities in the development of vaccines for emerging animal diseases, expansion into new geographical markets, and the adoption of advanced technologies such as mRNA vaccines and personalized medicine. These opportunities promise substantial future growth.
Leading Players in the Veterinary Vaccines Industry Market
- SPI Pharma
- Merck & Co Inc
- Zoetis
- OZ Biosciences
- Croda International PLC
- SEPPIC
- Invivogen
- Phibro Animal Health Corporation
- Bioveta AS
Key Developments in Veterinary Vaccines Industry
- December 2022: Evonik launched PhytoSquene, a non-animal-derived squalene for vaccine adjuvants. This significantly impacts the market by providing a sustainable alternative.
- June 2022: ICAR-NRC launched animal vaccines including an inactivated SARS-CoV-2 vaccine, demonstrating a response to emerging disease threats and expanding the market scope.
Future Outlook for Veterinary Vaccines Industry Market
The veterinary vaccines market is poised for continued growth driven by technological advancements, increasing demand from both livestock and companion animal sectors, and government initiatives supporting animal health. Strategic partnerships, expansion into emerging markets, and continued innovation will shape the future of this dynamic industry.
Veterinary Vaccines Industry Segmentation
-
1. Type
- 1.1. Alum and Calcium Salts
- 1.2. Oil Emulsion Adjuvants
- 1.3. Liposomes and Archaeosomes
- 1.4. Nanoparticles and Microparticles
- 1.5. Other Types
-
2. Route of Administration
- 2.1. Oral
- 2.2. Intramuscular
- 2.3. Other Routes of Administration
-
3. Animal Type
- 3.1. Livestock
- 3.2. Companion Animal
Veterinary Vaccines Industry Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. Europe
- 2.1. Germany
- 2.2. United Kingdom
- 2.3. France
- 2.4. Italy
- 2.5. Spain
- 2.6. Rest of Europe
-
3. Asia Pacific
- 3.1. China
- 3.2. Japan
- 3.3. India
- 3.4. Australia
- 3.5. South Korea
- 3.6. Rest of Asia Pacific
-
4. Middle East and Africa
- 4.1. GCC
- 4.2. South Africa
- 4.3. Rest of Middle East and Africa
-
5. South America
- 5.1. Brazil
- 5.2. Argentina
- 5.3. Rest of South America
Veterinary Vaccines Industry Regional Market Share
Geographic Coverage of Veterinary Vaccines Industry
Veterinary Vaccines Industry REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 7.2% from 2020-2034 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Rising Use of Adjuvants in Vaccines; Increasing Livestock Population and Associated Diseases; High Incidence of Diseases
- 3.3. Market Restrains
- 3.3.1. High Toxicity and Side Effects of Adjuvants
- 3.4. Market Trends
- 3.4.1. Companion Animal Segment is Expected to Witness Considerable Growth During the Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global Veterinary Vaccines Industry Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Type
- 5.1.1. Alum and Calcium Salts
- 5.1.2. Oil Emulsion Adjuvants
- 5.1.3. Liposomes and Archaeosomes
- 5.1.4. Nanoparticles and Microparticles
- 5.1.5. Other Types
- 5.2. Market Analysis, Insights and Forecast - by Route of Administration
- 5.2.1. Oral
- 5.2.2. Intramuscular
- 5.2.3. Other Routes of Administration
- 5.3. Market Analysis, Insights and Forecast - by Animal Type
- 5.3.1. Livestock
- 5.3.2. Companion Animal
- 5.4. Market Analysis, Insights and Forecast - by Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Middle East and Africa
- 5.4.5. South America
- 5.1. Market Analysis, Insights and Forecast - by Type
- 6. North America Veterinary Vaccines Industry Analysis, Insights and Forecast, 2020-2032
- 6.1. Market Analysis, Insights and Forecast - by Type
- 6.1.1. Alum and Calcium Salts
- 6.1.2. Oil Emulsion Adjuvants
- 6.1.3. Liposomes and Archaeosomes
- 6.1.4. Nanoparticles and Microparticles
- 6.1.5. Other Types
- 6.2. Market Analysis, Insights and Forecast - by Route of Administration
- 6.2.1. Oral
- 6.2.2. Intramuscular
- 6.2.3. Other Routes of Administration
- 6.3. Market Analysis, Insights and Forecast - by Animal Type
- 6.3.1. Livestock
- 6.3.2. Companion Animal
- 6.1. Market Analysis, Insights and Forecast - by Type
- 7. Europe Veterinary Vaccines Industry Analysis, Insights and Forecast, 2020-2032
- 7.1. Market Analysis, Insights and Forecast - by Type
- 7.1.1. Alum and Calcium Salts
- 7.1.2. Oil Emulsion Adjuvants
- 7.1.3. Liposomes and Archaeosomes
- 7.1.4. Nanoparticles and Microparticles
- 7.1.5. Other Types
- 7.2. Market Analysis, Insights and Forecast - by Route of Administration
- 7.2.1. Oral
- 7.2.2. Intramuscular
- 7.2.3. Other Routes of Administration
- 7.3. Market Analysis, Insights and Forecast - by Animal Type
- 7.3.1. Livestock
- 7.3.2. Companion Animal
- 7.1. Market Analysis, Insights and Forecast - by Type
- 8. Asia Pacific Veterinary Vaccines Industry Analysis, Insights and Forecast, 2020-2032
- 8.1. Market Analysis, Insights and Forecast - by Type
- 8.1.1. Alum and Calcium Salts
- 8.1.2. Oil Emulsion Adjuvants
- 8.1.3. Liposomes and Archaeosomes
- 8.1.4. Nanoparticles and Microparticles
- 8.1.5. Other Types
- 8.2. Market Analysis, Insights and Forecast - by Route of Administration
- 8.2.1. Oral
- 8.2.2. Intramuscular
- 8.2.3. Other Routes of Administration
- 8.3. Market Analysis, Insights and Forecast - by Animal Type
- 8.3.1. Livestock
- 8.3.2. Companion Animal
- 8.1. Market Analysis, Insights and Forecast - by Type
- 9. Middle East and Africa Veterinary Vaccines Industry Analysis, Insights and Forecast, 2020-2032
- 9.1. Market Analysis, Insights and Forecast - by Type
- 9.1.1. Alum and Calcium Salts
- 9.1.2. Oil Emulsion Adjuvants
- 9.1.3. Liposomes and Archaeosomes
- 9.1.4. Nanoparticles and Microparticles
- 9.1.5. Other Types
- 9.2. Market Analysis, Insights and Forecast - by Route of Administration
- 9.2.1. Oral
- 9.2.2. Intramuscular
- 9.2.3. Other Routes of Administration
- 9.3. Market Analysis, Insights and Forecast - by Animal Type
- 9.3.1. Livestock
- 9.3.2. Companion Animal
- 9.1. Market Analysis, Insights and Forecast - by Type
- 10. South America Veterinary Vaccines Industry Analysis, Insights and Forecast, 2020-2032
- 10.1. Market Analysis, Insights and Forecast - by Type
- 10.1.1. Alum and Calcium Salts
- 10.1.2. Oil Emulsion Adjuvants
- 10.1.3. Liposomes and Archaeosomes
- 10.1.4. Nanoparticles and Microparticles
- 10.1.5. Other Types
- 10.2. Market Analysis, Insights and Forecast - by Route of Administration
- 10.2.1. Oral
- 10.2.2. Intramuscular
- 10.2.3. Other Routes of Administration
- 10.3. Market Analysis, Insights and Forecast - by Animal Type
- 10.3.1. Livestock
- 10.3.2. Companion Animal
- 10.1. Market Analysis, Insights and Forecast - by Type
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis 2025
- 11.2. Company Profiles
- 11.2.1 SPI Pharma
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Financials (Based on Availability)
- 11.2.2 Merck & Co Inc
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Financials (Based on Availability)
- 11.2.3 Zoetis
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Financials (Based on Availability)
- 11.2.4 OZ Biosciences*List Not Exhaustive
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Financials (Based on Availability)
- 11.2.5 Croda International PLC
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Financials (Based on Availability)
- 11.2.6 SEPPIC
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Financials (Based on Availability)
- 11.2.7 Invivogen
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Financials (Based on Availability)
- 11.2.8 Phibro Animal Health Corporation
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Financials (Based on Availability)
- 11.2.9 Bioveta AS
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Financials (Based on Availability)
- 11.2.1 SPI Pharma
List of Figures
- Figure 1: Global Veterinary Vaccines Industry Revenue Breakdown (billion, %) by Region 2025 & 2033
- Figure 2: North America Veterinary Vaccines Industry Revenue (billion), by Type 2025 & 2033
- Figure 3: North America Veterinary Vaccines Industry Revenue Share (%), by Type 2025 & 2033
- Figure 4: North America Veterinary Vaccines Industry Revenue (billion), by Route of Administration 2025 & 2033
- Figure 5: North America Veterinary Vaccines Industry Revenue Share (%), by Route of Administration 2025 & 2033
- Figure 6: North America Veterinary Vaccines Industry Revenue (billion), by Animal Type 2025 & 2033
- Figure 7: North America Veterinary Vaccines Industry Revenue Share (%), by Animal Type 2025 & 2033
- Figure 8: North America Veterinary Vaccines Industry Revenue (billion), by Country 2025 & 2033
- Figure 9: North America Veterinary Vaccines Industry Revenue Share (%), by Country 2025 & 2033
- Figure 10: Europe Veterinary Vaccines Industry Revenue (billion), by Type 2025 & 2033
- Figure 11: Europe Veterinary Vaccines Industry Revenue Share (%), by Type 2025 & 2033
- Figure 12: Europe Veterinary Vaccines Industry Revenue (billion), by Route of Administration 2025 & 2033
- Figure 13: Europe Veterinary Vaccines Industry Revenue Share (%), by Route of Administration 2025 & 2033
- Figure 14: Europe Veterinary Vaccines Industry Revenue (billion), by Animal Type 2025 & 2033
- Figure 15: Europe Veterinary Vaccines Industry Revenue Share (%), by Animal Type 2025 & 2033
- Figure 16: Europe Veterinary Vaccines Industry Revenue (billion), by Country 2025 & 2033
- Figure 17: Europe Veterinary Vaccines Industry Revenue Share (%), by Country 2025 & 2033
- Figure 18: Asia Pacific Veterinary Vaccines Industry Revenue (billion), by Type 2025 & 2033
- Figure 19: Asia Pacific Veterinary Vaccines Industry Revenue Share (%), by Type 2025 & 2033
- Figure 20: Asia Pacific Veterinary Vaccines Industry Revenue (billion), by Route of Administration 2025 & 2033
- Figure 21: Asia Pacific Veterinary Vaccines Industry Revenue Share (%), by Route of Administration 2025 & 2033
- Figure 22: Asia Pacific Veterinary Vaccines Industry Revenue (billion), by Animal Type 2025 & 2033
- Figure 23: Asia Pacific Veterinary Vaccines Industry Revenue Share (%), by Animal Type 2025 & 2033
- Figure 24: Asia Pacific Veterinary Vaccines Industry Revenue (billion), by Country 2025 & 2033
- Figure 25: Asia Pacific Veterinary Vaccines Industry Revenue Share (%), by Country 2025 & 2033
- Figure 26: Middle East and Africa Veterinary Vaccines Industry Revenue (billion), by Type 2025 & 2033
- Figure 27: Middle East and Africa Veterinary Vaccines Industry Revenue Share (%), by Type 2025 & 2033
- Figure 28: Middle East and Africa Veterinary Vaccines Industry Revenue (billion), by Route of Administration 2025 & 2033
- Figure 29: Middle East and Africa Veterinary Vaccines Industry Revenue Share (%), by Route of Administration 2025 & 2033
- Figure 30: Middle East and Africa Veterinary Vaccines Industry Revenue (billion), by Animal Type 2025 & 2033
- Figure 31: Middle East and Africa Veterinary Vaccines Industry Revenue Share (%), by Animal Type 2025 & 2033
- Figure 32: Middle East and Africa Veterinary Vaccines Industry Revenue (billion), by Country 2025 & 2033
- Figure 33: Middle East and Africa Veterinary Vaccines Industry Revenue Share (%), by Country 2025 & 2033
- Figure 34: South America Veterinary Vaccines Industry Revenue (billion), by Type 2025 & 2033
- Figure 35: South America Veterinary Vaccines Industry Revenue Share (%), by Type 2025 & 2033
- Figure 36: South America Veterinary Vaccines Industry Revenue (billion), by Route of Administration 2025 & 2033
- Figure 37: South America Veterinary Vaccines Industry Revenue Share (%), by Route of Administration 2025 & 2033
- Figure 38: South America Veterinary Vaccines Industry Revenue (billion), by Animal Type 2025 & 2033
- Figure 39: South America Veterinary Vaccines Industry Revenue Share (%), by Animal Type 2025 & 2033
- Figure 40: South America Veterinary Vaccines Industry Revenue (billion), by Country 2025 & 2033
- Figure 41: South America Veterinary Vaccines Industry Revenue Share (%), by Country 2025 & 2033
List of Tables
- Table 1: Global Veterinary Vaccines Industry Revenue billion Forecast, by Type 2020 & 2033
- Table 2: Global Veterinary Vaccines Industry Revenue billion Forecast, by Route of Administration 2020 & 2033
- Table 3: Global Veterinary Vaccines Industry Revenue billion Forecast, by Animal Type 2020 & 2033
- Table 4: Global Veterinary Vaccines Industry Revenue billion Forecast, by Region 2020 & 2033
- Table 5: Global Veterinary Vaccines Industry Revenue billion Forecast, by Type 2020 & 2033
- Table 6: Global Veterinary Vaccines Industry Revenue billion Forecast, by Route of Administration 2020 & 2033
- Table 7: Global Veterinary Vaccines Industry Revenue billion Forecast, by Animal Type 2020 & 2033
- Table 8: Global Veterinary Vaccines Industry Revenue billion Forecast, by Country 2020 & 2033
- Table 9: United States Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 10: Canada Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 11: Mexico Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 12: Global Veterinary Vaccines Industry Revenue billion Forecast, by Type 2020 & 2033
- Table 13: Global Veterinary Vaccines Industry Revenue billion Forecast, by Route of Administration 2020 & 2033
- Table 14: Global Veterinary Vaccines Industry Revenue billion Forecast, by Animal Type 2020 & 2033
- Table 15: Global Veterinary Vaccines Industry Revenue billion Forecast, by Country 2020 & 2033
- Table 16: Germany Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 17: United Kingdom Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 18: France Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 19: Italy Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 20: Spain Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 21: Rest of Europe Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 22: Global Veterinary Vaccines Industry Revenue billion Forecast, by Type 2020 & 2033
- Table 23: Global Veterinary Vaccines Industry Revenue billion Forecast, by Route of Administration 2020 & 2033
- Table 24: Global Veterinary Vaccines Industry Revenue billion Forecast, by Animal Type 2020 & 2033
- Table 25: Global Veterinary Vaccines Industry Revenue billion Forecast, by Country 2020 & 2033
- Table 26: China Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 27: Japan Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 28: India Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 29: Australia Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 30: South Korea Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 31: Rest of Asia Pacific Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 32: Global Veterinary Vaccines Industry Revenue billion Forecast, by Type 2020 & 2033
- Table 33: Global Veterinary Vaccines Industry Revenue billion Forecast, by Route of Administration 2020 & 2033
- Table 34: Global Veterinary Vaccines Industry Revenue billion Forecast, by Animal Type 2020 & 2033
- Table 35: Global Veterinary Vaccines Industry Revenue billion Forecast, by Country 2020 & 2033
- Table 36: GCC Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 37: South Africa Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 38: Rest of Middle East and Africa Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 39: Global Veterinary Vaccines Industry Revenue billion Forecast, by Type 2020 & 2033
- Table 40: Global Veterinary Vaccines Industry Revenue billion Forecast, by Route of Administration 2020 & 2033
- Table 41: Global Veterinary Vaccines Industry Revenue billion Forecast, by Animal Type 2020 & 2033
- Table 42: Global Veterinary Vaccines Industry Revenue billion Forecast, by Country 2020 & 2033
- Table 43: Brazil Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 44: Argentina Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 45: Rest of South America Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Veterinary Vaccines Industry?
The projected CAGR is approximately 7.2%.
2. Which companies are prominent players in the Veterinary Vaccines Industry?
Key companies in the market include SPI Pharma, Merck & Co Inc, Zoetis, OZ Biosciences*List Not Exhaustive, Croda International PLC, SEPPIC, Invivogen, Phibro Animal Health Corporation, Bioveta AS.
3. What are the main segments of the Veterinary Vaccines Industry?
The market segments include Type, Route of Administration, Animal Type.
4. Can you provide details about the market size?
The market size is estimated to be USD 12.19 billion as of 2022.
5. What are some drivers contributing to market growth?
Rising Use of Adjuvants in Vaccines; Increasing Livestock Population and Associated Diseases; High Incidence of Diseases.
6. What are the notable trends driving market growth?
Companion Animal Segment is Expected to Witness Considerable Growth During the Forecast Period.
7. Are there any restraints impacting market growth?
High Toxicity and Side Effects of Adjuvants.
8. Can you provide examples of recent developments in the market?
In December 2022, Evonik launched non-animal-derived squalene suitable for vaccines and other pharmaceutical applications. PhytoSquene is the first known amaranth oil-derived squalene for use in adjuvants in parenteral dosage forms.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in billion.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Veterinary Vaccines Industry," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Veterinary Vaccines Industry report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Veterinary Vaccines Industry?
To stay informed about further developments, trends, and reports in the Veterinary Vaccines Industry, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence